Cost Effectiveness of Human Papillomavirus-16/18 Genotyping in Cervical Cancer Screening

被引：0
|
作者：
Warner K. Huh
Erin Williams
Joice Huang
Tommy Bramley
Nick Poulios
机构：
[1] University of Alabama at Birmingham,
[2] Xcenda,undefined
[3] Roche Molecular Diagnostics,undefined
来源：
Applied Health Economics and Health Policy | 2015年 / 13卷
关键词：
Cervical Cancer; Cervical Intraepithelial Neoplasia; Cervical Cancer Screening; Cervical Screening; Cervical Cancer Incidence;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：95 / 107
页数：12
相关论文
共 50 条
  • [31] The cost-effectiveness of human papillomavirus screening for cervical cancer: A review of recent modelling studies
    Holmes J.
    Hemmett L.
    Garfield S.
    The European Journal of Health Economics, 2005, 6 (1) : 30 - 37
  • [32] Cost-effectiveness of cervical cancer screening: cytology versus human papillomavirus DNA testing
    van Rosmalen, J.
    de Kok, I. M. C. M.
    van Ballegooijen, M.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2012, 119 (06) : 699 - 709
  • [33] HUMAN PAPILLOMAVIRUS-16 DNA IN A CUTANEOUS INVASIVE CANCER
    OSTROW, RS
    SHAVER, MK
    TURNQUIST, S
    VIKSNINS, A
    BENDER, M
    VANCE, C
    KAYE, V
    FARAS, AJ
    ARCHIVES OF DERMATOLOGY, 1989, 125 (05) : 666 - 669
  • [34] Cervical cancer screening: Impact of collection technique on human papillomavirus detection and genotyping
    Young, Alisa P.
    Olorunfemi, Mutiya
    Morrison, Leigh
    Kelley, Scott A.
    Laurie, Anna
    Mcevoy, Anna
    Schneiderhan, Jill
    Prussack, Julie
    O'Dwyer, Marie Claire
    Rockwell, Pamela
    Zazove, Philip
    Gabison, Jonathan
    Chargot, Jane
    Gallagher, Kristina
    Sen, Ananda
    Chen, Dongru
    Haro, Elizabeth A.
    Butcher, Emma A.
    Alves, Martha L.
    El Khoury, Christelle
    Dendrinos, Melinda L.
    Brashear, Nicole
    Smith, Roger
    Lieberman, Richard W.
    Saunders, Natalie
    Campbell, Elizabeth
    Walline, Heather M.
    Harper, Diane M.
    PREVENTIVE MEDICINE REPORTS, 2025, 50
  • [35] Clinical Utility of Human Papillomavirus Genotyping in Cervical Cancer Screening: A Systematic Review
    Bonde, Jesper H.
    Sandri, Maria-Teresa
    Gary, Devin S.
    Andrews, Jeffrey C.
    JOURNAL OF LOWER GENITAL TRACT DISEASE, 2020, 24 (01) : 1 - 13
  • [36] Cost-effectiveness of using human papillomavirus cancer screening
    Vijayaraghavan, Arthi
    Efrusy, Molly B.
    Goodman, Karyn A.
    Santas, Christopher C.
    Huh, Warner K.
    GYNECOLOGIC ONCOLOGY, 2010, 119 (02) : 237 - 242
  • [37] Cost-effectiveness analysis of the implementation of a quadrivalent (6,11,16,18 types) human papillomavirus vaccine to the existing Belgian cervical cancer screening programme
    Annemans, L.
    Remy, V
    Largeron, N.
    VALUE IN HEALTH, 2007, 10 (06) : A442 - A443
  • [38] HPV16 and HPV18 genotyping in cervical cancer screening
    Ronco, Guglielmo
    Franceschi, Silvia
    Segnan, Nereo
    LANCET ONCOLOGY, 2011, 12 (09): : 831 - 832
  • [39] Cost effectiveness of human papillomavirus testing to augment cervical cancer screening in women infected with the human immunodeficiency virus
    Goldie, SJ
    Freedberg, KA
    Weinstein, MC
    Wright, TC
    Kuntz, KM
    AMERICAN JOURNAL OF MEDICINE, 2001, 111 (02): : 140 - 149
  • [40] Primary Screening for Cervical Cancer Based on High-Risk Human Papillomavirus (HPV) Detection and HPV 16 and HPV 18 Genotyping, in Comparison to Cytology
    Agorastos, Theodoros
    Chatzistamatiou, Kimon
    Katsamagkas, Taxiarchis
    Koliopoulos, George
    Daponte, Alexandros
    Constantinidis, Theocharis
    Constantinidis, Theodoros C.
    PLOS ONE, 2015, 10 (03):
12345